Table of Content

1 Study Coverage
1.1 Adalimumab Injection Product Introduction
1.2 Market by Type
1.2.1 Global Adalimumab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 40mg/0.8ml
1.2.3 20mg/0.4ml
1.3 Market by Application
1.3.1 Global Adalimumab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Adalimumab Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Adalimumab Injection Revenue by Region
2.2.1 Global Adalimumab Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Adalimumab Injection Revenue by Region (2018-2024)
2.2.3 Global Adalimumab Injection Revenue by Region (2024-2029)
2.2.4 Global Adalimumab Injection Revenue Market Share by Region (2018-2029)
2.3 Global Adalimumab Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Adalimumab Injection Sales by Region
2.4.1 Global Adalimumab Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Adalimumab Injection Sales by Region (2018-2024)
2.4.3 Global Adalimumab Injection Sales by Region (2024-2029)
2.4.4 Global Adalimumab Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Adalimumab Injection Sales by Manufacturers
3.1.1 Global Adalimumab Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Adalimumab Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Adalimumab Injection in 2022
3.2 Global Adalimumab Injection Revenue by Manufacturers
3.2.1 Global Adalimumab Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Adalimumab Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Adalimumab Injection Revenue in 2022
3.3 Global Key Players of Adalimumab Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Adalimumab Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Adalimumab Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Adalimumab Injection, Product Offered and Application
3.8 Global Key Manufacturers of Adalimumab Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Adalimumab Injection Sales by Type
4.1.1 Global Adalimumab Injection Historical Sales by Type (2018-2024)
4.1.2 Global Adalimumab Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Adalimumab Injection Sales Market Share by Type (2018-2029)
4.2 Global Adalimumab Injection Revenue by Type
4.2.1 Global Adalimumab Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Adalimumab Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Adalimumab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Adalimumab Injection Price by Type
4.3.1 Global Adalimumab Injection Price by Type (2018-2024)
4.3.2 Global Adalimumab Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Adalimumab Injection Sales by Application
5.1.1 Global Adalimumab Injection Historical Sales by Application (2018-2024)
5.1.2 Global Adalimumab Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Adalimumab Injection Sales Market Share by Application (2018-2029)
5.2 Global Adalimumab Injection Revenue by Application
5.2.1 Global Adalimumab Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Adalimumab Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Adalimumab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Adalimumab Injection Price by Application
5.3.1 Global Adalimumab Injection Price by Application (2018-2024)
5.3.2 Global Adalimumab Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Adalimumab Injection Market Size by Type
6.1.1 US & Canada Adalimumab Injection Sales by Type (2018-2029)
6.1.2 US & Canada Adalimumab Injection Revenue by Type (2018-2029)
6.2 US & Canada Adalimumab Injection Market Size by Application
6.2.1 US & Canada Adalimumab Injection Sales by Application (2018-2029)
6.2.2 US & Canada Adalimumab Injection Revenue by Application (2018-2029)
6.3 US & Canada Adalimumab Injection Market Size by Country
6.3.1 US & Canada Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Adalimumab Injection Sales by Country (2018-2029)
6.3.3 US & Canada Adalimumab Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Adalimumab Injection Market Size by Type
7.1.1 Europe Adalimumab Injection Sales by Type (2018-2029)
7.1.2 Europe Adalimumab Injection Revenue by Type (2018-2029)
7.2 Europe Adalimumab Injection Market Size by Application
7.2.1 Europe Adalimumab Injection Sales by Application (2018-2029)
7.2.2 Europe Adalimumab Injection Revenue by Application (2018-2029)
7.3 Europe Adalimumab Injection Market Size by Country
7.3.1 Europe Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Adalimumab Injection Sales by Country (2018-2029)
7.3.3 Europe Adalimumab Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Adalimumab Injection Market Size
8.1.1 China Adalimumab Injection Sales (2018-2029)
8.1.2 China Adalimumab Injection Revenue (2018-2029)
8.2 China Adalimumab Injection Market Size by Application
8.2.1 China Adalimumab Injection Sales by Application (2018-2029)
8.2.2 China Adalimumab Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Adalimumab Injection Market Size by Type
9.1.1 Asia Adalimumab Injection Sales by Type (2018-2029)
9.1.2 Asia Adalimumab Injection Revenue by Type (2018-2029)
9.2 Asia Adalimumab Injection Market Size by Application
9.2.1 Asia Adalimumab Injection Sales by Application (2018-2029)
9.2.2 Asia Adalimumab Injection Revenue by Application (2018-2029)
9.3 Asia Adalimumab Injection Sales by Region
9.3.1 Asia Adalimumab Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Adalimumab Injection Revenue by Region (2018-2029)
9.3.3 Asia Adalimumab Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Adalimumab Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Adalimumab Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Adalimumab Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Adalimumab Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Adalimumab Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Adalimumab Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Adalimumab Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Adalimumab Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Adalimumab Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AbbVie Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Amgen Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Sandoz
11.3.1 Sandoz Company Information
11.3.2 Sandoz Overview
11.3.3 Sandoz Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sandoz Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sandoz Recent Developments
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Information
11.4.2 Fresenius Kabi Overview
11.4.3 Fresenius Kabi Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Fresenius Kabi Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fresenius Kabi Recent Developments
11.5 Biogen
11.5.1 Biogen Company Information
11.5.2 Biogen Overview
11.5.3 Biogen Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Biogen Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biogen Recent Developments
11.6 Celltrion
11.6.1 Celltrion Company Information
11.6.2 Celltrion Overview
11.6.3 Celltrion Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Celltrion Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Celltrion Recent Developments
11.7 Cadila Pharmaceuticals
11.7.1 Cadila Pharmaceuticals Company Information
11.7.2 Cadila Pharmaceuticals Overview
11.7.3 Cadila Pharmaceuticals Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Cadila Pharmaceuticals Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cadila Pharmaceuticals Recent Developments
11.8 Bio-Thera Solutions, Ltd.
11.8.1 Bio-Thera Solutions, Ltd. Company Information
11.8.2 Bio-Thera Solutions, Ltd. Overview
11.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Thera Solutions, Ltd. Recent Developments
11.9 Hisun Biopharmaceutical
11.9.1 Hisun Biopharmaceutical Company Information
11.9.2 Hisun Biopharmaceutical Overview
11.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Hisun Biopharmaceutical Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hisun Biopharmaceutical Recent Developments
11.10 Innovent Biologics
11.10.1 Innovent Biologics Company Information
11.10.2 Innovent Biologics Overview
11.10.3 Innovent Biologics Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Innovent Biologics Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Innovent Biologics Recent Developments
11.11 Mylan
11.11.1 Mylan Company Information
11.11.2 Mylan Overview
11.11.3 Mylan Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Mylan Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mylan Recent Developments
11.12 Zydus Group
11.12.1 Zydus Group Company Information
11.12.2 Zydus Group Overview
11.12.3 Zydus Group Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Zydus Group Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zydus Group Recent Developments
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Information
11.13.2 Boehringer Ingelheim Overview
11.13.3 Boehringer Ingelheim Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Boehringer Ingelheim Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Boehringer Ingelheim Recent Developments
11.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
11.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
11.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Overview
11.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
11.15 Shanghai Henlius Biotech
11.15.1 Shanghai Henlius Biotech Company Information
11.15.2 Shanghai Henlius Biotech Overview
11.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Shanghai Henlius Biotech Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shanghai Henlius Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Adalimumab Injection Industry Chain Analysis
12.2 Adalimumab Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Adalimumab Injection Production Mode & Process
12.4 Adalimumab Injection Sales and Marketing
12.4.1 Adalimumab Injection Sales Channels
12.4.2 Adalimumab Injection Distributors
12.5 Adalimumab Injection Customers
13 Market Dynamics
13.1 Adalimumab Injection Industry Trends
13.2 Adalimumab Injection Market Drivers
13.3 Adalimumab Injection Market Challenges
13.4 Adalimumab Injection Market Restraints
14 Key Findings in The Global Adalimumab Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Adalimumab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 40mg/0.8ml
Table 3. Major Manufacturers of 20mg/0.4ml
Table 4. Global Adalimumab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Adalimumab Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Adalimumab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Adalimumab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Adalimumab Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Adalimumab Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Adalimumab Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Adalimumab Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Adalimumab Injection Sales by Region (2024-2029) & (K Units)
Table 13. Global Adalimumab Injection Sales Market Share by Region (2018-2024)
Table 14. Global Adalimumab Injection Sales Market Share by Region (2024-2029)
Table 15. Global Adalimumab Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Adalimumab Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Adalimumab Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Adalimumab Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Adalimumab Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Adalimumab Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Adalimumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Adalimumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adalimumab Injection as of 2022)
Table 23. Global Key Manufacturers of Adalimumab Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Adalimumab Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Adalimumab Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 29. Global Adalimumab Injection Sales Share by Type (2018-2024)
Table 30. Global Adalimumab Injection Sales Share by Type (2024-2029)
Table 31. Global Adalimumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Adalimumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Adalimumab Injection Revenue Share by Type (2018-2024)
Table 34. Global Adalimumab Injection Revenue Share by Type (2024-2029)
Table 35. Adalimumab Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Adalimumab Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 39. Global Adalimumab Injection Sales Share by Application (2018-2024)
Table 40. Global Adalimumab Injection Sales Share by Application (2024-2029)
Table 41. Global Adalimumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Adalimumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Adalimumab Injection Revenue Share by Application (2018-2024)
Table 44. Global Adalimumab Injection Revenue Share by Application (2024-2029)
Table 45. Adalimumab Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Adalimumab Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Adalimumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Adalimumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Adalimumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Adalimumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Adalimumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 60. Europe Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 62. Europe Adalimumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Adalimumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 66. Europe Adalimumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Adalimumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Adalimumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 73. China Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 75. China Adalimumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Adalimumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 79. China Adalimumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Adalimumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 83. Asia Adalimumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Adalimumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 87. Asia Adalimumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Adalimumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Adalimumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Adalimumab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Adalimumab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Adalimumab Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Adalimumab Injection Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Adalimumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Adalimumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Adalimumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Adalimumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Adalimumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 107. AbbVie Company Information
Table 108. AbbVie Description and Major Businesses
Table 109. AbbVie Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AbbVie Recent Developments
Table 112. Amgen Company Information
Table 113. Amgen Description and Major Businesses
Table 114. Amgen Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Amgen Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen Recent Developments
Table 117. Sandoz Company Information
Table 118. Sandoz Description and Major Businesses
Table 119. Sandoz Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sandoz Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sandoz Recent Developments
Table 122. Fresenius Kabi Company Information
Table 123. Fresenius Kabi Description and Major Businesses
Table 124. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Fresenius Kabi Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Fresenius Kabi Recent Developments
Table 127. Biogen Company Information
Table 128. Biogen Description and Major Businesses
Table 129. Biogen Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Biogen Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biogen Recent Developments
Table 132. Celltrion Company Information
Table 133. Celltrion Description and Major Businesses
Table 134. Celltrion Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Celltrion Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Celltrion Recent Developments
Table 137. Cadila Pharmaceuticals Company Information
Table 138. Cadila Pharmaceuticals Description and Major Businesses
Table 139. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Cadila Pharmaceuticals Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Cadila Pharmaceuticals Recent Developments
Table 142. Bio-Thera Solutions, Ltd. Company Information
Table 143. Bio-Thera Solutions, Ltd. Description and Major Businesses
Table 144. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bio-Thera Solutions, Ltd. Recent Developments
Table 147. Hisun Biopharmaceutical Company Information
Table 148. Hisun Biopharmaceutical Description and Major Businesses
Table 149. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Hisun Biopharmaceutical Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hisun Biopharmaceutical Recent Developments
Table 152. Innovent Biologics Company Information
Table 153. Innovent Biologics Description and Major Businesses
Table 154. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Innovent Biologics Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Innovent Biologics Recent Developments
Table 157. Mylan Company Information
Table 158. Mylan Description and Major Businesses
Table 159. Mylan Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Mylan Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Mylan Recent Developments
Table 162. Zydus Group Company Information
Table 163. Zydus Group Description and Major Businesses
Table 164. Zydus Group Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Zydus Group Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Zydus Group Recent Developments
Table 167. Boehringer Ingelheim Company Information
Table 168. Boehringer Ingelheim Description and Major Businesses
Table 169. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Boehringer Ingelheim Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Boehringer Ingelheim Recent Developments
Table 172. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
Table 173. Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Major Businesses
Table 174. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
Table 177. Shanghai Henlius Biotech Company Information
Table 178. Shanghai Henlius Biotech Description and Major Businesses
Table 179. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shanghai Henlius Biotech Adalimumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Shanghai Henlius Biotech Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Adalimumab Injection Distributors List
Table 185. Adalimumab Injection Customers List
Table 186. Adalimumab Injection Market Trends
Table 187. Adalimumab Injection Market Drivers
Table 188. Adalimumab Injection Market Challenges
Table 189. Adalimumab Injection Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Adalimumab Injection Product Picture
Figure 2. Global Adalimumab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Adalimumab Injection Market Share by Type in 2022 & 2029
Figure 4. 40mg/0.8ml Product Picture
Figure 5. 20mg/0.4ml Product Picture
Figure 6. Global Adalimumab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Adalimumab Injection Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Adalimumab Injection Report Years Considered
Figure 12. Global Adalimumab Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Adalimumab Injection Revenue 2018-2029 (US$ Million)
Figure 14. Global Adalimumab Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Adalimumab Injection Revenue Market Share by Region (2018-2029)
Figure 16. Global Adalimumab Injection Sales 2018-2029 ((K Units)
Figure 17. Global Adalimumab Injection Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Adalimumab Injection Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Adalimumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Adalimumab Injection Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Adalimumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Adalimumab Injection Sales YoY (2018-2029) & (K Units)
Figure 23. China Adalimumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Adalimumab Injection Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Adalimumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Adalimumab Injection Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Adalimumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Adalimumab Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Adalimumab Injection in the World: Market Share by Adalimumab Injection Revenue in 2022
Figure 30. Global Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Adalimumab Injection Sales Market Share by Type (2018-2029)
Figure 32. Global Adalimumab Injection Revenue Market Share by Type (2018-2029)
Figure 33. Global Adalimumab Injection Sales Market Share by Application (2018-2029)
Figure 34. Global Adalimumab Injection Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Adalimumab Injection Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Adalimumab Injection Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Adalimumab Injection Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Adalimumab Injection Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Adalimumab Injection Revenue Share by Country (2018-2029)
Figure 40. US & Canada Adalimumab Injection Sales Share by Country (2018-2029)
Figure 41. U.S. Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Adalimumab Injection Sales Market Share by Type (2018-2029)
Figure 44. Europe Adalimumab Injection Revenue Market Share by Type (2018-2029)
Figure 45. Europe Adalimumab Injection Sales Market Share by Application (2018-2029)
Figure 46. Europe Adalimumab Injection Revenue Market Share by Application (2018-2029)
Figure 47. Europe Adalimumab Injection Revenue Share by Country (2018-2029)
Figure 48. Europe Adalimumab Injection Sales Share by Country (2018-2029)
Figure 49. Germany Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 50. France Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 54. China Adalimumab Injection Sales Market Share by Type (2018-2029)
Figure 55. China Adalimumab Injection Revenue Market Share by Type (2018-2029)
Figure 56. China Adalimumab Injection Sales Market Share by Application (2018-2029)
Figure 57. China Adalimumab Injection Revenue Market Share by Application (2018-2029)
Figure 58. Asia Adalimumab Injection Sales Market Share by Type (2018-2029)
Figure 59. Asia Adalimumab Injection Revenue Market Share by Type (2018-2029)
Figure 60. Asia Adalimumab Injection Sales Market Share by Application (2018-2029)
Figure 61. Asia Adalimumab Injection Revenue Market Share by Application (2018-2029)
Figure 62. Asia Adalimumab Injection Revenue Share by Region (2018-2029)
Figure 63. Asia Adalimumab Injection Sales Share by Region (2018-2029)
Figure 64. Japan Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 68. India Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Adalimumab Injection Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Adalimumab Injection Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Adalimumab Injection Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Adalimumab Injection Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Adalimumab Injection Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Adalimumab Injection Sales Share by Country (2018-2029)
Figure 75. Brazil Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Adalimumab Injection Revenue (2018-2029) & (US$ Million)
Figure 80. Adalimumab Injection Value Chain
Figure 81. Adalimumab Injection Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed